| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | CEO - Elect
1 company
Kim Julie So-Young is a President And CEO at TKPHF. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $13.3M at current prices.
Kim Julie So-Young's largest disclosed position is in TKPHF as President And CEO, worth about $13.3M. The recent filings there lean toward selling, a net 89,090 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | TKPHF Takeda Pharmaceutical Company Limited | President And CEO | Sell | 89,090 | $17.10 | $1,523,439.00 | -18.5% |